Study 2 was a phase 3b, multicenter, open label, single arm study to evaluate treatment of moderate facial and truncal AV baseline IGA 3, 20 inflammatory lesions and 25 noninflammatory lesions on the face, in addition to 20 100 inflammatory lesions and 20 noninflammatory lesions on the trunk shoulders, upper back, and upper anterior chest with trifarotene 0 <a href=https://cialiss.quest>cheapest cialis generic online</a> were dropped from the investigation